Callie Parker

Callie is an experienced MedTech leader with a strong record for growth and talent development. In her 15 years with Johnson & Johnson, Callie has held roles of increasing responsibility across Electrophysiology, Neurovascular, and Vision in multiple functions and geographies.

Her deep experience in electrophysiology and interventional solutions helped her lead the Electrophysiology EMEA region to profitable growth despite the unprecedented challenges of the pandemic by prioritizing investment and development in human capital, redefining strategy, implementing new governance around SGP improvement, and placing a focus on commercial execution. She is a Credo-driven leader who creates a culture of innovation, resilience, collaboration, and customer focus.

Prior to that, Callie was Global Strategic Support Director, Cardiovascular and Specialty Solutions and J&J Vision, where she played a crucial role in shaping strategic priorities across the portfolio of businesses and functions around the globe.

In 2016, she was appointed Area Director for the Western U.S. and, before that, worked in Belgium as Marketing Manager – both for Electrophysiology. Serving on the leadership board, she led and worked on several project teams to shape the new organizational structure, which propelled the company to achieve the significant milestone of $1B in annual sales.

She was the co-lead for the Southern California Women’s Leadership Initiative and carried out several development events and community service projects during her tenure. She also spent several successful years in the US market building high-performing sales and clinical teams that led to exponential growth.

Callie holds a degree in Business Communications from Florida State University. She has served and worked on MedTech EMEA’s sustainability programs and continues to act as the EMEA Spark Ambassador for Inclusion efforts across the region. She currently lives in Zurich with her two daughters.